Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kronox Lab Sciences reported FY26 revenue of Rs. 10,122 Lacs, up marginally by ~1% from Rs. 10,018 Lacs in FY25. Profit after tax grew 8.7% to Rs. 2,766 Lacs from Rs. 2,546 Lacs, while EPS improved from Rs. 6.81 to Rs. 7.51. Q4 FY26 showed stronger PAT growth of ~27% at Rs. 800 Lacs versus Rs. 632 Lacs in Q4 FY25. The Board recommended a dividend of 5% (Rs. 0.50 per share of Rs. 10 face value). Statutory auditors issued an unmodified (clean) opinion on the audited results. The company operates in a single segment manufacturing high purity specialty fine chemicals.
Steady profit growth with improving margins despite flat revenue signals operational efficiency gains. The clean audit and dividend declaration are positive signals for shareholders.